Impact of implementation process on long-acting cabotegravir/rilpivirine prescription at 9 HIV clinics, 2021-2024.

Lujintanon S, Lesko CR, Haw NJL, Hickey MD, Zalla LC, Kilcrease C, Grochowski J, Hill LA, Cachay ER, Budak JZ, Crane HM, Fleming J, Mayer KH, Rutstein SE, Turner B, Nevin C, Burkholder GA, Wang N, Yendewa GA, Moss R, Pettit A, Rodriguez AE, Johnson MO, Christopoulos KA

Open source

DOI: 10.1097/qai.0000000000003970
Published: 2026 Aug 31
Container: Journal of acquired immune deficiency syndromes (1999)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/qai.0000000000003970,
  title = {Impact of implementation process on long-acting cabotegravir/rilpivirine prescription at 9 HIV clinics, 2021-2024.},
  author = {Lujintanon S and Lesko CR and Haw NJL and Hickey MD and Zalla LC and Kilcrease C and Grochowski J and Hill LA and Cachay ER and Budak JZ and Crane HM and Fleming J and Mayer KH and Rutstein SE and Turner B and Nevin C and Burkholder GA and Wang N and Yendewa GA and Moss R and Pettit A and Rodriguez AE and Johnson MO and Christopoulos KA},
  year = {2026},
  journal = {Journal of acquired immune deficiency syndromes (1999)},
  doi = {10.1097/qai.0000000000003970},
  url = {https://doi.org/10.1097/qai.0000000000003970}
}

RIS

TY  - JOUR
TI  - Impact of implementation process on long-acting cabotegravir/rilpivirine prescription at 9 HIV clinics, 2021-2024.
AU  - Lujintanon S
AU  - Lesko CR
AU  - Haw NJL
AU  - Hickey MD
AU  - Zalla LC
AU  - Kilcrease C
AU  - Grochowski J
AU  - Hill LA
AU  - Cachay ER
AU  - Budak JZ
AU  - Crane HM
AU  - Fleming J
AU  - Mayer KH
AU  - Rutstein SE
AU  - Turner B
AU  - Nevin C
AU  - Burkholder GA
AU  - Wang N
AU  - Yendewa GA
AU  - Moss R
AU  - Pettit A
AU  - Rodriguez AE
AU  - Johnson MO
AU  - Christopoulos KA
PY  - 2026
JO  - Journal of acquired immune deficiency syndromes (1999)
DO  - 10.1097/qai.0000000000003970
UR  - https://doi.org/10.1097/qai.0000000000003970
ER  -

APA

S, L., CR, L., NJL, H., MD, H., LC, Z., C, K., J, G., LA, H., ER, C., JZ, B., HM, C., J, F., KH, M., SE, R., B, T., C, N., GA, B., N, W., GA, Y., R, M., A, P., AE, R., MO, J., & KA, C. (2026). Impact of implementation process on long-acting cabotegravir/rilpivirine prescription at 9 HIV clinics, 2021-2024.. Journal of acquired immune deficiency syndromes (1999). https://doi.org/10.1097/qai.0000000000003970

Source records

pubmed · retrieved 2026-09-26T09:05:29.132Z